
|Articles|January 13, 2017
Biosimilar Payment Models Highlight Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top news of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/biosimilar-payment-models-highlight-week-in-specia" target="_blank">View the story "Biosimilar Payment Models Highlight Week in Specialty Pharmacy" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
4
Notable Updates in Medication Therapy Management in 2025
5









































































































































































































